Your browser doesn't support javascript.
loading
BRCC3 Promotes Tumorigenesis of Bladder Cancer by Activating the NF-κB Signaling Pathway Through Targeting TRAF2.
Tao, Huangheng; Liao, Yixiang; Yan, Youji; He, Zhiwen; Zhou, Jiajie; Wang, Xinghuan; Peng, Jianping; Li, Shangze; Liu, Tao.
Affiliation
  • Tao H; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Liao Y; Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Yan Y; State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory for Oral Biomedicine of Ministry of Education (KLOBM), School and Hospital of Stomatology, Wuhan University, Wuhan, China.
  • He Z; Jingzhou Hospital, Yangtze University, Jingzhou, China.
  • Zhou J; The Second Clinical Medical College, Yangtze University, Jingzhou, China.
  • Wang X; Jingzhou Hospital, Yangtze University, Jingzhou, China.
  • Peng J; The Second Clinical Medical College, Yangtze University, Jingzhou, China.
  • Li S; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Liu T; Medical Science Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
Front Cell Dev Biol ; 9: 720349, 2021.
Article in En | MEDLINE | ID: mdl-34604222
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Cell Dev Biol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Cell Dev Biol Year: 2021 Document type: Article Affiliation country: China Country of publication: Switzerland